"Dual Mobility in High Risk Patients"

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

412

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

June 1, 2025

Study Completion Date

February 1, 2035

Conditions
Dislocation, Hip
Interventions
DEVICE

Dual mobility implant

Patients that are eligible and consent to the study will be randomized to receive either a dual mobility implant or a traditional single-bearing hip implant. This group is for the dual mobility implant

DEVICE

Traditional, Single-bearing hip implant

Patients that are eligible and consent to the study will be randomized to receive either a dual mobility implant or a traditional single-bearing hip implant. This group is for the dual mobility implant

Trial Locations (4)

10003

New York University Medical Center, New York

19107

Rothman Orthopaedic Institute, Philadelphia

60612

Rush University Medical Center, Chicago

90033

Keck School of Medicine of USC, Los Angeles

All Listed Sponsors
collaborator

New York University

OTHER

collaborator

Rothman Institute Orthopaedics

OTHER

collaborator

Keck School of Medicine of USC

OTHER

lead

Rush University Medical Center

OTHER